PL2459222T3 - Lepki, miękki żel do traktowania drobiu - Google Patents

Lepki, miękki żel do traktowania drobiu

Info

Publication number
PL2459222T3
PL2459222T3 PL10803770T PL10803770T PL2459222T3 PL 2459222 T3 PL2459222 T3 PL 2459222T3 PL 10803770 T PL10803770 T PL 10803770T PL 10803770 T PL10803770 T PL 10803770T PL 2459222 T3 PL2459222 T3 PL 2459222T3
Authority
PL
Poland
Prior art keywords
soft gel
treating poultry
sticky soft
sticky
poultry
Prior art date
Application number
PL10803770T
Other languages
English (en)
Inventor
Eng-Hong Lee
Original Assignee
Ceva Animal Health Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ceva Animal Health Inc. filed Critical Ceva Animal Health Inc.
Publication of PL2459222T3 publication Critical patent/PL2459222T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/163—Sugars; Polysaccharides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K40/00—Shaping or working-up of animal feeding-stuffs
    • A23K40/10—Shaping or working-up of animal feeding-stuffs by agglomeration; by granulation, e.g. making powders
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
    • A23K50/75—Feeding-stuffs specially adapted for particular animals for birds for poultry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A61K39/17—Newcastle disease virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Birds (AREA)
  • Animal Husbandry (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Pulmonology (AREA)
  • Nutrition Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PL10803770T 2009-07-28 2010-07-27 Lepki, miękki żel do traktowania drobiu PL2459222T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51092609A 2009-07-28 2009-07-28
CA2674143 2009-07-28

Publications (1)

Publication Number Publication Date
PL2459222T3 true PL2459222T3 (pl) 2017-09-29

Family

ID=43528666

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10803770T PL2459222T3 (pl) 2009-07-28 2010-07-27 Lepki, miękki żel do traktowania drobiu

Country Status (14)

Country Link
US (1) US8900623B2 (pl)
EP (1) EP2459222B1 (pl)
CN (1) CN102481371B (pl)
BR (1) BR112012001938B1 (pl)
CA (1) CA2769223C (pl)
EA (1) EA024592B1 (pl)
EG (1) EG26998A (pl)
ES (1) ES2628452T3 (pl)
HU (1) HUE033213T2 (pl)
PE (1) PE20121347A1 (pl)
PL (1) PL2459222T3 (pl)
PT (1) PT2459222T (pl)
WO (1) WO2011011873A1 (pl)
ZA (1) ZA201201009B (pl)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2464522C (en) 2004-04-15 2011-11-15 Eng-Hong Lee Soft gel delivery system for treating poultry
CN103689288B (zh) * 2013-12-20 2015-07-22 大连赛姆生物工程技术有限公司 一种羊自主采食型植物源复合药效营养品及其制备方法
CN103689228B (zh) * 2013-12-20 2015-07-22 大连赛姆生物工程技术有限公司 一种猪自主采食型植物源复合药效营养品及其制备方法
CN103704522B (zh) * 2013-12-20 2015-12-09 大连赛姆生物工程技术有限公司 一种鸡自主采食型植物源复合药效营养品及其制备方法
CN103704520B (zh) * 2013-12-20 2016-03-16 大连赛姆生物工程技术有限公司 一种鸭自主采食型植物源复合药效营养品及其制备方法
CN103734520B (zh) * 2013-12-20 2015-07-22 大连赛姆生物工程技术有限公司 一种马自主采食型植物源复合药效营养品及其制备方法
CN103704521B (zh) * 2013-12-20 2016-03-09 大连赛姆生物工程技术有限公司 一种牛自主采食型植物源复合药效营养品及其制备方法
CN106063523A (zh) * 2015-04-20 2016-11-02 上海绿奥生物科技有限公司 促进南美白对虾生长的新型复合益生菌多糖胶及其应用
EP3334289B1 (en) 2015-08-14 2019-10-02 Clearh2o, Inc. High throughput process for delivering semi-firm gel for poultry
EP3397278A1 (en) 2015-12-29 2018-11-07 Intervet International B.V. Coccidiosis vaccine
EP3558350A1 (en) * 2016-12-22 2019-10-30 Intervet International B.V. Eimeria vaccine with improved efficacy
HRP20241698T1 (hr) * 2018-11-08 2025-05-09 Biochem Zusatzstoffe Handels- und Produktionsges. mbH Praškasti pripravak i pripravak gela koji sadrže akvatične fotosintetske organizme
CN111330001B (zh) * 2020-03-24 2022-05-20 中国农业大学 一种兔球虫病减毒活疫苗助悬剂及悬浮液
FR3168165A1 (fr) 2024-11-07 2026-05-08 Ceva Sante Animale Suspensions polymeriques et compositions les comprenant pour vacciner la volaille

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1204057A (en) * 1982-06-22 1986-05-06 Eng-Hong Lee Immunization against coccidiosis
US5985336A (en) * 1995-06-07 1999-11-16 Novus International, Inc. Nutrient formulation and process for feeding young poultry and other animals
AU2002327338A1 (en) * 2001-07-25 2003-02-17 New York University Use of glycosylceramides as adjuvants for vaccines against infections and cancer
KR100485145B1 (ko) * 2002-06-03 2005-04-25 윤정민 식용잉크 조성물
US9561182B2 (en) * 2003-08-22 2017-02-07 Cure Pharmaceutical Corporation Edible films for administration of medicaments to animals, methods for their manufacture and methods for their use for the treatment of animals
CA2416726A1 (en) * 2003-01-20 2004-07-20 Eng-Hong Lee Soft gel vaccine delivery system for treating poultry
US20070059346A1 (en) * 2003-07-01 2007-03-15 Todd Maibach Film comprising therapeutic agents
CN1829490A (zh) * 2003-07-01 2006-09-06 托德·迈巴赫 包含治疗剂的薄膜
US20050095336A1 (en) * 2003-11-04 2005-05-05 Pete Maletto Low carbohydrate ice cream
CA2464522C (en) 2004-04-15 2011-11-15 Eng-Hong Lee Soft gel delivery system for treating poultry
EP1757268B1 (en) * 2004-06-07 2017-07-05 Kureha Corporation Dry-form composition for oral ingestion and gel-form composition for oral ingestion of type prepared at time of use
DE102006044447B4 (de) * 2006-09-14 2013-06-20 Manfred Helms Gelartiges Basenpräparat auf Basis ätherischer Ölmischungen zur dermalen und transdermalen Anwendung
JP4913537B2 (ja) * 2006-10-20 2012-04-11 青葉化成株式会社 食品用しみ込み抑制剤、粘性食品および浸透性食品
KR100853301B1 (ko) * 2007-04-13 2008-08-21 주식회사 제닉 이수 방지 기능을 갖는 하이드로겔 조성물 및 이를포함하는 성형체
MX2010008038A (es) * 2008-01-28 2010-08-30 Archer Daniels Midland Co Composiciones para alimentar animales.

Also Published As

Publication number Publication date
US8900623B2 (en) 2014-12-02
PT2459222T (pt) 2017-06-26
PE20121347A1 (es) 2012-10-26
EG26998A (en) 2015-03-22
BR112012001938A2 (pt) 2016-03-15
HUE033213T2 (hu) 2017-11-28
CA2769223C (en) 2015-03-17
EP2459222A1 (en) 2012-06-06
EA201270201A1 (ru) 2012-07-30
CA2769223A1 (en) 2011-02-03
BR112012001938B1 (pt) 2020-05-05
CN102481371A (zh) 2012-05-30
EP2459222B1 (en) 2017-03-15
EP2459222A4 (en) 2012-12-26
BR112012001938A8 (pt) 2017-09-19
WO2011011873A1 (en) 2011-02-03
US20120121644A1 (en) 2012-05-17
ZA201201009B (en) 2012-10-31
ES2628452T3 (es) 2017-08-02
CN102481371B (zh) 2014-04-16
EA024592B1 (ru) 2016-10-31

Similar Documents

Publication Publication Date Title
EG26998A (en) Sticky soft gel for treating poultry
EP2522633A4 (en) DEVICE FOR HYDROGENATING A BIOCOMPATIBLE SOLUTION
EP2593045A4 (en) INTERSPINAL FIXING IMPLANT
IL224771A (en) Skin Care Device
IL212793A0 (en) Handpiece for treating skin
GB2474058B (en) Cosmetic Surgery Apparatus
PL2391391T3 (pl) Sposób sterylizacji
PL2459003T3 (pl) Obsypane pożywienie dla zwierząt
IL223063A (en) Device for selective hydrogenation of biologically adapted solution
PL2432410T3 (pl) Sztuczne zapłodnienie
ZA201303469B (en) Method and instalation for killing poultry
GB2473540B (en) Animal training apparatus
AU330716S (en) Pet treat
AU330717S (en) Pet treat
AU332252S (en) Pet treat
IL217492A0 (en) Treatment method
ZA201101556B (en) Method for treatment of natural rubber products
IL220594A0 (en) Treatment method
EP2420555A4 (en) MODIFYING AGENT FOR PLASTIC FATS
GB0921719D0 (en) Surgical apparatus
ZA201206957B (en) Sterilising apparatus
PL2454946T3 (pl) Sposób odsalania tkanki zwierzęcej
GB2471341B (en) Fishing apparatus
IL218120A0 (en) Sterilization method
GB0914464D0 (en) Animal collar-guard